tiprankstipranks
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
Holding LXRX?
Track your performance easily

Lexicon Pharmaceuticals (LXRX) Stock Investors

1,405 Followers
Based on 769,002 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold LXRX
On average, investors allocate 4.76% of their portfolios to LXRX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 769,002 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding LXRX

0.3%
Last 7
Days
2.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding LXRX, out of 769,002 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

LXRX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,695 investors who made their portfolios public
The table shows changes in LXRX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

LXRX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Plug Power
5.20%
-1.18%
-0.87%
1.75B
Industrials
Viking Therapeutics
4.53%
+0.19%
+7.08%
5.74B
Healthcare
DraftKings
5.47%
-1.55%
+0.62%
38.05B
Consumer Cyclical
Bristol-Myers Squibb
3.56%
-0.57%
-1.16%
118.10B
Healthcare
XPeng, Inc. ADR
5.51%
-1.45%
-1.51%
12.63B
Consumer Cyclical
Carnival
6.44%
-0.18%
+7.66%
31.45B
Consumer Cyclical
Enphase Energy
4.53%
-0.55%
+2.56%
8.29B
Technology
Block
4.46%
+0.68%
+2.99%
56.87B
Technology
Riot Platforms
5.30%
-0.05%
+1.92%
4.08B
Financial
Li Auto
5.57%
-1.96%
-4.55%
23.18B
Consumer Cyclical
Based on the activity of 769,002 active portfolios
Open your Smart Portfolio

LXRX Investor Analysis

LXRX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.8%
of LXRX holders
are under 35
Average Segment Performance
Average P/E Ratio29.47
Beta10.82
Dividend Yield99.38%
LXRX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
61.3%
of LXRX holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.86
Beta20.87
Dividend Yield46.37%
LXRX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
28.0%
of LXRX holders
are over 55
Average Segment Performance
Average P/E Ratio25.26
Beta9.51
Dividend Yield77.60%
Overview of age group and performance of LXRX stock investors
See who invests in LXRX according to age group and performance.

FAQ

How many retail Investors hold LXRX?
<0.1% of TipRanks' retail investors hold LXRX in their portfolios.
    What is LXRX Investor Sentiment?
    LXRX’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of LXRX in the last 7 days?
      ▲ 0.3% of TipRanks' retail investors changed their holding of LXRX in the last 7 days.
        What percentage of retail investors changed their holding of LXRX in the last 30 days?
        ▲ 2.0% of TipRanks' retail investors changed their holding of LXRX in the last 30 days.
          What is the average age of retail investors who hold LXRX?
          The average age of LXRX Holders is between 35–55.
            What other stocks have LXRX investors also bought?
            LXRX Investors also bought PLUG, VKTX, DKNG, BMY, XPEV, CCL, ENPH, SQ, RIOT, LI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CNCCentene
              CRMDCormedix
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis